History of mergers and acquisitions
| Company *company acquired | Year | Product/s marketed or in clinical pipeline | Small molecules | Peptides | Biologics | Technology platform | Geographic expansion | |
| Pervasis Therapeutics | 2012 | Vascugel |  | | ||||
| *FerroKin BioSciences | 2012 | FBS0701 | | |||||
| *Advanced BioHealing (ABH) | 2011 | DERMAGRAFT | ||||||
| *Movetis | 2010 | RESOLOR, M0002, M0003 | | | | |||
| Santaris | 2009 | Three pre-defined targets | | |||||
| UCB | 2009 | EQUASYM | | | ||||
| *Jerini AG | 2008 | FIRAZYR | | | ||||
| Zymenex | 2008 | HGT 111 (Metazym) | | |||||
| Renovo | 2007 | JUVISTA | | |||||
| *New River | 2007 | VYVANSE | | | ||||
| *Transkaryotic Therapies Inc | 2005 | ELAPRASE, REPLAGAL velaglucerase alfa | | | | |||
| Noven | 2002 | DAYTRANA | | |||||
| Guiliani | 2002 | LIALDA / MEZAVANT | | |||||
| Atlantic Pharmaceutical | 2002 | n/a | ||||||
| *BioChem pharma | 2001 | Royalty products | | | ||||
| *Roberts | 1999 | XAGRID, PENTSA | | | ||||
| *Fuisz EU | 1999 | n/a | | | ||||
| *Richwood | 1997 | ADDERALL (XR) | | | ||||
| *Pharmavene | 1997 | CARBATROL | | | ||||
| Imperials | 1995 |
